Literature DB >> 17434339

Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression.

Giulia Morsica1, Sabrina Bagaglio, Silvia Ghezzi, Chiara Lodrini, Elisa Vicenzi, Elena Santagostino, Alessandro Gringeri, Marco Cusini, Guido Carminati, Giampaolo Bianchi, Laura Galli, Adriano Lazzarin, Guido Poli.   

Abstract

BACKGROUND AND
OBJECTIVE: Hepatitis C virus (HCV) infection is frequent in HIV-positive subjects. We evaluated the potential impact of HCV coinfection and other determinants on HIV disease progression in a cohort of long-term non-progressors (LTNPs). STUDY
DESIGN: We studied immunological and virological factors in a cohort of 49 LTNPs, 23 of whom progressed during the follow-up (late progressors; LPs).
RESULTS: HCV coinfection was detected in 19/26 LTNPs and 15/23 LPs. Univariate analysis showed that HIV viral load was associated with disease progression (P=0.04), and time-to-event analysis indicated that HCV genotype 1 significantly correlated with LTNP status (P=0.031). At multivariate analysis, HIV viremia at study entry remained independently associated with LTNP status (P=0.049). When the most represented genotypes (1 and 3a) were considered in the model, genotype 3a infection (P=0.034) and gender (P=0.035) emerged as independent variables related to HIV disease progression, whereas HIV viral load disappeared.
CONCLUSIONS: In addition to HIV viremia, coinfection with different HCV genotypes and gender may affect LTNP status.

Entities:  

Mesh:

Year:  2007        PMID: 17434339     DOI: 10.1016/j.jcv.2007.03.007

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  6 in total

Review 1.  Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.

Authors:  Yaron Rotman; T Jake Liang
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

2.  Hepatitis C infection in HIV-1 natural viral suppressors.

Authors:  Mohammad M Sajadi; Nahzinine Shakeri; Rohit Talwani; Robert R Redfield
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

3.  Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients.

Authors:  Stefan Reuter; Mark Oette; Frank Clemens Wilhelm; Bastian Beggel; Rolf Kaiser; Melanie Balduin; Finja Schweitzer; Jens Verheyen; Ortwin Adams; Thomas Lengauer; Gerd Fätkenheuer; Herbert Pfister; Dieter Häussinger
Journal:  Med Microbiol Immunol       Date:  2010-09-19       Impact factor: 3.402

4.  Transcriptomic assay of CD8+ T cells in treatment-naïve HIV, HCV-mono-infected and HIV/HCV-co-infected Chinese.

Authors:  Jin Zhao; Lina Yi; Jing Lu; Zheng-Rong Yang; Ying Chen; Chenli Zheng; Dan Huang; Yu-Feng Li; Lin Chen; Jinquan Cheng; Hsiang-Fu Kung; Ming-Liang He
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

5.  Elite controllers long-term non progressors present improved survival and slower disease progression.

Authors:  Laura Capa; Rubén Ayala-Suárez; Humberto Erick De La Torre Tarazona; Juan González-García; Jorge Del Romero; José Alcamí; Francisco Díez-Fuertes
Journal:  Sci Rep       Date:  2022-09-29       Impact factor: 4.996

6.  HCV coinfection associated with slower disease progression in HIV-infected former plasma donors naïve to ART.

Authors:  Xiaoyan Zhang; Jianqing Xu; Hong Peng; Yan Ma; Lifeng Han; Yuhua Ruan; Bing Su; Ning Wang; Yiming Shao
Journal:  PLoS One       Date:  2008-12-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.